8 Global events
11,644 Executive-level attendees attracted
48,347 One-to-one partnering meetings held
6,673 Attending companies
60 Countries represented
12,193 Licensing opportunities on offer
The Covid-19 pandemic is creating unprecedented healthcare challenges with far reaching effects yet to be measured. There is a need for greater collaboration and communication among researchers, healthcare systems, government agencies, NGOs, and the public at large. Behind the scenes, the biopharma industry is rallying to innovate and collaborate to develop diagnostics, vaccines and treatments as quickly as possible.
Industry leaders in China share insights from the outbreak and highlight the opportunities and challenges ahead, including what strategies can be deployed to prepare for the future. Key learnings will be discussed to determine the best path forward as we work towards a new normal.
Ninety-five percent of VCs add zero value to a startup other than cash, said tech venture capitalist Vinod Khosla. He explained that about four out of every five VCs actually damage their own investments with bad advice.
So who out there is more than just a checkbook? Which VCs bring value to the table, in the form of useful introductions or strategy?
We consistently provide valuable in-depth insight and analysis on the most recent trends in life science and partnering. Don't miss the latest releases!
partneringONE has new features for each EBD Group event. With ONE login, you access the entire event. For our digital events this means no need to switch back and forth between multiple platforms. Search by company or therapeutic area to discover potential partners and relevant conference sessions and company presentations. This easy-to-use digital solution is your "one stop shop" for all conference activities!
Watch this short video to learn more and register for one of our upcoming events to launch your digital partnering journey.
Our network of more than 40,000 high-value dealmakers, companies and assets from around the world are looking for "best-fit" partners.
Find out moreFacilitating strategic connections
that drive life science dealmaking.